Effect of estrogen plus progestin on stroke in the women's health initiative

被引：0
|
作者：
Wassertheil-Smoller, S
Hendrix, S
Heiss, G
Limacher, M
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Wayne State Univ, Detroit, MI USA
[3] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA
[4] Univ Gainesville, Gainesville, FL USA
来源：
STROKE | 2003年 / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
  • [31] Hormone therapy and venous thrombosis: Final results of the Women's Health Initiative trial of estrogen plus progestin.
    Cushman, M
    Kuller, LH
    Prentice, R
    Psaty, BM
    Sidney, S
    Stafford, R
    Rodabough, R
    Rosendaal, FR
    BLOOD, 2003, 102 (11) : 208A - 208A
  • [32] Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures - The Women's Health Initiative randomized trial
    Anderson, GL
    Judd, HL
    Kaunitz, AM
    Barad, DH
    Beresford, SAA
    Pettinger, M
    Liu, J
    McNeeley, SG
    Lopez, AM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (13): : 1739 - 1748
  • [33] Estrogen metabolism in menopausal hormone users in the women's health initiative observational study: Does it differ between estrogen plus progestin and estrogen alone?
    Falk, Roni T.
    Manson, JoAnn E.
    Barnabei, Vanessa M.
    Anderson, Garnet L.
    Brinton, Louise A.
    Rohan, Thomas E.
    Cauley, Jane A.
    Chen, Chu
    Coburn, Sally B.
    Pfeiffer, Ruth M.
    Reding, Kerryn W.
    Sarto, Gloria E.
    Wentzensen, Nicolas
    Chlebowski, Rowan T.
    Xu, Xia
    Trabert, Britton
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (04) : 730 - 740
  • [34] Estrogen metabolism in menopausal hormone users: Does it differ between estrogen plus progestin and estrogen alone users in the Women's Health Initiative Observational Study
    Falk, Roni T.
    Anderson, Garnet L.
    Barnabei, Vanessa M.
    Brinton, Louise A.
    Cauley, Jane A.
    Chen, Chu
    Chlebowski, Rowan T.
    Coburn, Sally B.
    Manson, JoAnn E.
    Pfeiffer, Ruth M.
    Reding, Kerryn W.
    Rohan, Thomas E.
    Sarto, Gloria E.
    Wentzensen, Nicolas
    Trabert, Britton
    CANCER RESEARCH, 2017, 77
  • [35] Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial - Comments
    Tucker, G
    CLIMACTERIC, 2003, 6 (04) : 310 - 312
  • [36] Issues to debate on the Women's Health Initiative Study - Failure of estrogen plus progestin therapy for prevention of breast cancer risk
    Luukkainen, T
    HUMAN REPRODUCTION, 2003, 18 (08) : 1559 - 1561
  • [37] Estrogen plus progestin and coronary heart disease risk: Final results from the women's health initiative randomized trial
    Hsia, J
    Manson, JE
    Johnson, KC
    Assaf, AR
    Lasser, NL
    Trevisan, M
    Black, HR
    Heckbert, SR
    Detrano, R
    Wong, ND
    Crouse, JR
    Stein, E
    Cushman, M
    CIRCULATION, 2003, 108 (17) : 787 - 787
  • [38] Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks
    Aedo, Socrates
    Cavada, Gabriel
    Bluemel, Juan E.
    Chedraui, Peter
    Fica, Juan
    Barriga, Patricio
    Brantes, Sergio
    Irribarra, Cristina
    Vallejo, Maria
    Campodonico, Italo
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1317 - 1322
  • [39] Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial - Reply
    Shapiro, S
    CLIMACTERIC, 2003, 6 (04) : 313 - 313
  • [40] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
    Rossouw, JE
    Anderson, GL
    Prentice, RL
    LaCroix, AZ
    Kooperberg, C
    Stefanick, ML
    Jackson, RD
    Beresford, SAA
    Howard, BV
    Johnson, KC
    Kotchen, JM
    Ockene, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 321 - 333
12345